We are seeking solutions for
e-llas.

The e-llas call is now closed.

What is e-llas?

e-llas is GSK’s innovation hub focused on gynaecological cancer.

It is conceived with the purpose of finding solutions to the specific needs of these patients. Our goal is to promote innovation and entrepreneurship through active collaboration within the healthcare ecosystem. 

The Challenges 

How might we achieve earlier diagnosis of gynaecologic cancer to enhance the management and prognosis of the disease?

How might we provide comprehensive support to patients diagnosed with gynaecological cancer to facilitate the disease's journey?

We are seeking innovative technologies to help us address the challenges:

Your solution could be the chosen one.

Discover what we offer

Growth

Explore new opportunities with the potential to establish a collaborative agreement with GSK. Develop and implement your solution with the vision of making it accessible and scalable at both national and international levels. 

Learning

Receive guidance and support in aspects related to research, development, and strategy within the healthcare sector. Additionally, benefit from our expertise in regulatory, legal, and operational matters. 

Connection

Facilitate access to healthcare professionals, patients, companies, and other organizations aligned with the purpose of your solution. Collaborate with relevant stakeholders in the sector to collectively address the challenge.

Our Partners

ellas is a collaborative space that encourages the involvement of patient associations, healthcare professionals, expert companies, and other stakeholders in the innovation and healthcare ecosystem.

With a comprehensive understanding of the environment, we aim to anticipate needs and generate solutions that enhance healthcare for patients with gynaecological cancer. 

News

Stay informed about the activities, events, and news of e-llas